IndiaHealthcare and life sciences2024 – ongoingAIIMS New Delhi
iOncology.ai support for breast and ovarian cancer diagnosis
AIIMS reported extending iOncology.ai to 5 district hospitals after patient use
Problem
AIIMS sought additional support for detecting breast and ovarian cancers. Missed diagnoses could delay treatment.
Approach
AIIMS and C-DAC developed iOncology.ai through a government-supported research collaboration. Its deep-learning models used clinical information and medical images. AIIMS reported using it on actual patients to validate clinical diagnoses before implementation at district hospitals.
Results
Takeaway
Clinical use and hospital expansion were reported, but AIIMS did not disclose a measured diagnostic accuracy or patient-outcome improvement.
Categories
- Size
- Large enterprise
- Industry
- Healthcare and life sciences
- Business function
- Production and quality
- Innovation type
- Process innovation
- AI technology
- Computer visionPredictive analytics and ML
- Adoption
- Partner co-development
- Goal
- Quality and risk
- Evidence
- Company's own claim
Sources
Source summaries
The report relayed an AIIMS statement describing patient use of iOncology.ai. AIIMS said the platform had subsequently been implemented at 5 district hospitals.
Full details are in the original sources.